Tumours shrank or stopped growing in almost one in three women (31 per cent) with low-grade serous ovarian cancer, which does ...

Almost a third (31%) of women with low-grade serous ovarian cancer, which does not respond well to chemotherapy, saw their ...

Scientists say the Royal Marsden hospitals' drug trial could change practice globally for serous form of ovarian cancer which ...

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to ...

A combination of two drugs which can block the growth of cancer cells has shown promising results in women with a form of ...

A groundbreaking study has uncovered the origin of one of the most aggressive forms of ovarian cancer, called high-grade ...

【导读】化疗后的疾病复发是卵巢癌(OC)的一个主要临床挑战，但关于肿瘤表观基因组如何调节支持化疗耐药的转录程序，我们知之甚少。9月28日，英国伯明翰大学研究学者在期刊《Communications Biology》上发表了题为“The ...

The completion of a new drug application for the combination of avutometinib and defactinib in KRAS-mutant ovarian cancer is ...

H.C. Wainwright analyst Sean Lee CFA has maintained their bullish stance on VSTM stock, giving a Buy rating yesterday. Sean Lee CFA has given ...

Researchers have identified the origin of ovarian cancer that develops in the fallopian tube, which opens doors to ...

Researchers say that in the course of developing a new model for ovarian cancer, they've developed additional evidence that serous uterine cancer possibly begins in the fallopian tubes, not the uterus ...